← Leaderboards
Kathleen Conway Dorsey
University Of North Carolina Chapel Hill
$2,612,133
Attributed
$3,355,840
Total exposure
8
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $388.2K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,355,840 · 8
By mechanism
R33$979,154 · 1
R01$779,640 · 1
P50$674,016 · 2
R21$356,261 · 1
R03$301,720 · 2
N01$265,049 · 1
Top collaborators
- Nancy E Thomas7 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Nancy E Thomas$10,693,117
- Aziz Sancar$33,098,063
- Dale A Ramsden$16,926,520
Others in their field
Top investigators on “Staging”
- Richard K. Wilson · Washington University$281,315,172
- David Heimbrook · Leidos Biomedical Research, Inc.$277,888,083
- Chanza Baytop · Westat, Inc.$271,217,917
- Francis L Halzen · University Of Wisconsin-Madison$208,995,120
- Demian A Bailey · Oregon State University$199,999,984
- Clare E Reimers · Gordon Research Conferences$199,999,984
Research focus
StagingGenesTumorNeoplasm /Cancer GeneticsSamplingMolecularNeoplasm MetastasisBenignNevi And MelanomasEarly DiagnosisMole The MammalPromotor (Genetics)Benign Melanocytic NevusHistologicDiagnosisNevusDiagnosticMelanomaAppearanceBreast NeoplasmsMalignant NeoplasmsFormalinNeoplasm /Cancer EpidemiologyParaffin Embedding
Grant awards (17)
TERT Promoter Mutation as a Melanoma Biomarker$76,000
R03 · FY2016 · CA
TERT Promoter Mutation as a Melanoma Biomarker$76,000
R03 · FY2015 · CA
Detection of Tumor DNA in Plasma from Carolina Breast Cancer Study Patients$73,720
R03 · FY2014 · CA · contact PI
High-Throughput DNA-Methylation Profiling from Fixed Melanocytic Tissues$312,242
R33 · FY2013 · CA
Detection of Tumor DNA in Plasma from Carolina Breast Cancer Study Patients$76,000
R03 · FY2013 · CA · contact PI
High-Throughput DNA-Methylation Profiling from Fixed Melanocytic Tissues$330,935
R33 · FY2012 · CA
High-Throughput DNA-Methylation Profiling from Fixed Melanocytic Tissues$335,977
R33 · FY2011 · CA
DNA-Methylation Profiling from Fixed Melanocytic Tissues$161,932
R21 · FY2010 · CA
DNA-Methylation Profiling from Fixed Melanocytic Tissues$194,329
R21 · FY2009 · CA
Molecular Epidemiology of Smoking &Breast Cancer$259,880
R01 · FY2005 · CA
Molecular Epidemiology of Smoking &Breast Cancer$259,880
R01 · FY2004 · CA
Molecular Epidemiology of Smoking &Breast Cancer$259,880
R01 · FY2003 · CA
CORE--MOLECULAR ANALYSIS AND HIGH THROUGHPUT GENOTYPING$168,504
P50 · FY2002 · CA
H-RAS RARE ALLELES IN BREAST CANCER SUSCEPTIBILITY$168,504
P50 · FY2001 · CA
CORE--MOLECULAR ANALYSIS AND HIGH THROUGHPUT GENOTYPING$168,504
P50 · FY2001 · CA
ONCOGENE ANALYSIS FOR EPIDEMIOLOGIC STUDIES$265,049
N01 · FY2000 · ES
H-RAS RARE ALLELES IN BREAST CANCER SUSCEPTIBILITY$168,504
P50 · FY2000 · CA